<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>RxGen &#124; Therapeutic Development Through Innovative Research</title>
	<atom:link href="http://rx-gen.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://rx-gen.com</link>
	<description>Therapeutic Development Through Innovative Research</description>
	<lastBuildDate>Thu, 26 Apr 2012 15:28:47 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Iris Pharma &amp; RxGen Announce Strategic Alliance</title>
		<link>http://rx-gen.com/iris-pharma-rxgen-announce-strategic-alliance/</link>
		<comments>http://rx-gen.com/iris-pharma-rxgen-announce-strategic-alliance/#comments</comments>
		<pubDate>Thu, 19 Apr 2012 08:00:54 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://rx-gen.com/?p=441</guid>
		<description><![CDATA[Iris Pharma and RxGen Partner to Deliver Seamless and Superior Drug &#38; Medical Devices Development Services in Ophthalmology &#160; Nice, France, and Hamden, CT, USA, April 19, 2012 – Iris Pharma, a leading ophthalmic preclinical and clinical contract research organization (CRO), and RxGen, a specialty preclinical CRO focused on the development and application of translational research [...]]]></description>
		<wfw:commentRss>http://rx-gen.com/iris-pharma-rxgen-announce-strategic-alliance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RxGen &amp; Miragen Secure SBIR Funding to Evaluate Role of microRNAs in Cardiac Disease</title>
		<link>http://rx-gen.com/rxgen-miragen-secure-sbir-fund-microrna-research-for-cardiac-applications/</link>
		<comments>http://rx-gen.com/rxgen-miragen-secure-sbir-fund-microrna-research-for-cardiac-applications/#comments</comments>
		<pubDate>Thu, 25 Aug 2011 17:43:08 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://rx-gen.com/?p=401</guid>
		<description><![CDATA[HAMDEN, Conn., and BOULDER, Colo., August 25, 2011 – RxGen, a specialty preclinical contract research organization, and miRagen Therapeutics, Inc., a preclinical-stage biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the award of a Small Business Innovation Research (SBIR) grant by the National [...]]]></description>
		<wfw:commentRss>http://rx-gen.com/rxgen-miragen-secure-sbir-fund-microrna-research-for-cardiac-applications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RxGen Optimizes the CNV model of Wet-AMD in Nonhuman Primates</title>
		<link>http://rx-gen.com/rxgen-optimizes-cnv-model-of-wetamd-nonhuman-primates-addressing-study-design-limitations-improve-preclinical-evaluations/</link>
		<comments>http://rx-gen.com/rxgen-optimizes-cnv-model-of-wetamd-nonhuman-primates-addressing-study-design-limitations-improve-preclinical-evaluations/#comments</comments>
		<pubDate>Mon, 21 Mar 2011 03:34:33 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://rx-gen.com/?p=362</guid>
		<description><![CDATA[Hamden, CT &#8212; March 21, 2011 &#8212; RxGen, a specialty preclinical contract research organization, announced today that Experimental Eye Research has published results of efforts to optimize the laser-induced choroidal neovascularization (CNV) model in nonhuman primates, which is routinely employed to evaluate candidate compounds or drug delivery devices designed to treat wet-AMD. Despite widespread use [...]]]></description>
		<wfw:commentRss>http://rx-gen.com/rxgen-optimizes-cnv-model-of-wetamd-nonhuman-primates-addressing-study-design-limitations-improve-preclinical-evaluations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AAALAC Accreditation Awarded to RxGen Research Facilities</title>
		<link>http://rx-gen.com/aaalac-accreditation-awarded-rxgen-research-facilities/</link>
		<comments>http://rx-gen.com/aaalac-accreditation-awarded-rxgen-research-facilities/#comments</comments>
		<pubDate>Mon, 27 Sep 2010 03:32:36 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://rx-gen.com/?p=354</guid>
		<description><![CDATA[Hamden, CT &#8212; September 27, 2010 &#8212; RxGen, a specialty preclinical contract research organization, announced today that its research facilities have received full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International. RxGen’s research facilities are housed at the St. Kiits Biomedical Research Foundation (SKBRF) in St. Kitts, West Indies, [...]]]></description>
		<wfw:commentRss>http://rx-gen.com/aaalac-accreditation-awarded-rxgen-research-facilities/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RxGen Validates African Green Monkey Model of Wet-AMD</title>
		<link>http://rx-gen.com/rxgen-validates-african-green-monkey-model-of-wet-amd/</link>
		<comments>http://rx-gen.com/rxgen-validates-african-green-monkey-model-of-wet-amd/#comments</comments>
		<pubDate>Sun, 02 May 2010 05:31:30 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://rx-gen.com/?p=231</guid>
		<description><![CDATA[HAMDEN, CT May 2, 2010 – RxGen scientists have completed the validation of the laser-induced CNV model of wet-AMD in the African green monkey, migrating a disease model previously validated in other non-human primates to a species that offers considerable advantages with respect to both availability and genomic and anatomic similarity to humans. RxGen is [...]]]></description>
		<wfw:commentRss>http://rx-gen.com/rxgen-validates-african-green-monkey-model-of-wet-amd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RxGen Hosts Second Annual “microRNA in Human Disease” Meeting with Santaris Pharma</title>
		<link>http://rx-gen.com/rxgen-hosts-second-annual-%e2%80%9cmicrorna-in-human-disease%e2%80%9d-meeting-with-santaris-pharma/</link>
		<comments>http://rx-gen.com/rxgen-hosts-second-annual-%e2%80%9cmicrorna-in-human-disease%e2%80%9d-meeting-with-santaris-pharma/#comments</comments>
		<pubDate>Mon, 15 Mar 2010 04:48:15 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://rx-gen.com/?p=228</guid>
		<description><![CDATA[HAMDEN, CT March 15, 2010 – RxGen announces the successful conclusion of its second annual microRNA in Human Disease meeting, co-hosted and sponsored by Santaris Pharma and miRagen. This year’s meeting was designed to extend upon the unique format established in 2009, whereby leading principal investigators and postdoctoral scientists working in multiple aspects of microRNA [...]]]></description>
		<wfw:commentRss>http://rx-gen.com/rxgen-hosts-second-annual-%e2%80%9cmicrorna-in-human-disease%e2%80%9d-meeting-with-santaris-pharma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

